Pharmaceutical firms are keen on reclassification of drugs
Published: 2011-07-07 06:58:00
Updated: 2011-07-07 06:58:00
As a number of prescription drugs, including an anti-ulcerant Zantac and a contraceptive Norlevo, are likely be reclassified into over-the-counter (OTC) drugs, some pharmaceutical firms are said to seek to expand pharmacy sales of more OTC drugs.
An official at a major pharmaceutical company s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
